Previous 10 | Next 10 |
2023-03-23 08:08:44 ET Summary Halvorsen's 13F portfolio value decreased from $21.66B to ~$19.98B this quarter. The number of positions decreased from 88 to 53. Viking Global increased Amazon and UnitedHealth while decreasing General Electric, Meta Platforms, and Boston Scientific...
2023-03-09 07:54:11 ET The big expansion of the retail investing crowd could make a coming economic slump even more pronounced, according to those who subscribe to the Wealth Effect theory. The Wealth Effect postulates that consumption increases as wealth in market portfolios and re...
(NewsDirect) Blackstone Minerals Ltd (ASX:BSX) MD Scott Williamson tells Proactive the company continues to optimise project development strategies through its ongoing engagement with prospective technology and offtake partners at the company’s Ta Khoa Refinery Project (TKR) in Norther...
2023-03-06 11:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
(NewsDirect) Digbee Limited founder and CEO Jamie Strauss and Blackstone Minerals Ltd (ASX:BSX, OTCQX:BLSTF) managing director Scott Williamson speak to Proactive's Thomas Warner about the independent ESG assessment Digbee recently completed with Blackrock. Williamson reveals the key takeaway...
Summary Revenue should benefit from a healthy backlog, good end-market demand, China's economic reopening, and new product innovations. Margins should benefit from price increases, volume leverage, and easing supply chain conditions. Valuation multiple can re-rate higher which coupl...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes trading in ...
Summary Stryker posted impressive top-line growth in Q4, driven by mid-teens growth in the MedSurg & Neuro operations. Margins remain a drag as Stryker has struggled to offset higher input costs. I see upside potential in FY'23 revenue, with Stryker launching several significant...
Summary Haemonetics surpassed sell-side expectations with healthy revenue growth from Plasma and Hospital, but margin leverage was lacking due to the ongoing impact of inflation and supply chain issues. The company extended its non-exclusive supply agreement with CSL for another two yea...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes trading in ...
News, Short Squeeze, Breakout and More Instantly...
Boston Scientific Corporation Company Name:
BSX Stock Symbol:
NYSE Market:
Boston Scientific Corporation Website:
Alkermes plc (ALKS) is expected to report $0.64 for Q2 2024 Acerinox ADR (ANIOY) is expected to report for Q2 2024 Allegion plc (ALLE) is expected to report $1.77 for Q2 2024 Deutsche Bank AG (DB) is expected to report $0.43 for Q2 2024 Pathward Financial Inc. (CASH) is expected t...
Boston Scientific Announces Results for Second Quarter 2024 PR Newswire MARLBOROUGH, Mass. , July 24, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $4.120 billion during the second quarter of 2024, growing 14.5 percent ...
Shares of Boston Scientific Corporation (NYSE: BSX) traded at a new 52-week high today and are currently trading at $78.31. So far today, approximately 1.5M shares have been exchanged, as compared to an average 30-day volume of 5.37M shares. Boston Scientific Corporation develops, manufacture...